Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mainak Banerjee
Subhadeep Gupta
Rimesh Pal
Sujoy Ghosh

Showing results (1-10 of 611) with videos related to

Pageof 62
Sort By:
Primary Care Diabetes|August 18, 2020
Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?Rimesh Pal, Mainak Banerjee
Primary Care Diabetes|June 2, 2022
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysisMainak Banerjee, Rimesh Pal, Sulagna Dutta
Indian Pediatrics|June 26, 2020
COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the DuumvirateSukrita Bhattacharjee, Mainak Banerjee, Rimesh Pal
Diabetes, Obesity & Metabolism|October 9, 2025
Histological efficacy of anti-diabetic agents in MASH and the mediating role of weight loss: A network meta-analysisMainak Banerjee, Rimesh Pal, Sandip Pal
Diabetes & Metabolic Syndrome|April 21, 2020
Diabetes self-management amid COVID-19 pandemicMainak Banerjee, Soumen Chakraborty, Rimesh Pal
Acta Diabetologica|March 6, 2022
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysisMainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay
Diabetic Medicine : a Journal of the British Diabetic Association|January 9, 2021
Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta-analysis of randomized controlled trialsRimesh Pal, Mainak Banerjee, Sanjay Kumar Bhadada
Diabetes & Metabolic Syndrome|January 11, 2024
GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysisMainak Banerjee, Rimesh Pal, Indira Maisnam, et al.
Diabetes & Metabolic Syndrome|August 28, 2020
Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literatureRimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2023
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay, et al.
Pageof 62

Showing results (1-10 of 611) with videos related to

Sort By:
Pageof 62
Primary Care Diabetes|August 18, 2020
Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?Rimesh Pal, Mainak Banerjee
Primary Care Diabetes|June 2, 2022
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysisMainak Banerjee, Rimesh Pal, Sulagna Dutta
Indian Pediatrics|June 26, 2020
COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the DuumvirateSukrita Bhattacharjee, Mainak Banerjee, Rimesh Pal
Diabetes, Obesity & Metabolism|October 9, 2025
Histological efficacy of anti-diabetic agents in MASH and the mediating role of weight loss: A network meta-analysisMainak Banerjee, Rimesh Pal, Sandip Pal
Diabetes & Metabolic Syndrome|April 21, 2020
Diabetes self-management amid COVID-19 pandemicMainak Banerjee, Soumen Chakraborty, Rimesh Pal
Acta Diabetologica|March 6, 2022
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysisMainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay
Diabetic Medicine : a Journal of the British Diabetic Association|January 9, 2021
Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta-analysis of randomized controlled trialsRimesh Pal, Mainak Banerjee, Sanjay Kumar Bhadada
Diabetes & Metabolic Syndrome|January 11, 2024
GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysisMainak Banerjee, Rimesh Pal, Indira Maisnam, et al.
Diabetes & Metabolic Syndrome|August 28, 2020
Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literatureRimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2023
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay, et al.
Pageof 62